Latest AI and machine learning research in chemotherapy for healthcare professionals.
The transition from laparoscopic to robotic surgery for left-sided colorectal cancer raises safety concerns during the learning curve, particularly when complex cases are preferentially selected for the robotic platform. We evaluated a machine learning-based framework for risk-adjusted safety monitoring of robotic implementation, using outcomes from an established laparoscopic program as the refer...
Non-small cell lung cancer (NSCLC) presents persistent challenges in immunotherapy, as the clinical benefit of programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors is frequently constrained by intrinsic and acquired resistance. Central contributors include impaired antigen presentation, T cell exclusion, and the accumulation of immunosuppressive populations that ...
Antibody-drug conjugates (ADCs) are complex biotherapeutics that combine the selectivity of monoclonal antibodies with the potency of cytotoxic payloa...
Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, remains a major global health concern due to its high incidence and mort...
BACKGROUND: Given the potential of artificial intelligence (AI) and the increasing importance of understanding AI's economic impact, this study aims t...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Accurate prognostic modeling enables reliable risk stratification to identi...
Ovarian cancer is one of the most lethal gynecological malignancies, asymptomatic early progression, ineffective screening, and high histological hete...
BACKGROUND: Delayed chemotherapy-induced nausea and vomiting (CINV) in pediatric oncology patients is currently under-recognized. This study aims to d...
BACKGROUND: Meningiomas are the most common dural-based intracranial tumors, yet Indian literature is predominantly composed of limited single-center ...
BACKGROUND: Predicting chemosensitivity before treatment could help tailor neoadjuvant chemotherapy (NAC) in early breast cancer (eBC). Pathological c...
Neoadjuvant immunochemotherapy (NAIC) is a standard treatment for triple-negative breast cancer (TNBC), but there is no reliable biomarker to identify...
Tumor-intrinsic biomarkers alone insufficiently predict pathological complete response (pCR) to neoadjuvant immunochemotherapy (NICT) in non-small cel...
Multidisciplinary team (MDT) discussions have become a cornerstone of colorectal cancer (CRC) management, integrating the expertise of surgeons, oncol...
OBJECTIVES: Chemotherapy-induced cardiotoxicity is still a major clinical problem, usually appearing subclinically before structural or symptomatic ca...
Follicular lymphoma (FL), traditionally considered an indolent yet incurable malignancy, is experiencing a substantial evolution in its therapeutic la...
INTRODUCTION: Obesity is an established risk factor for chronic kidney disease (CKD). However, excess visceral adipose tissue (VAT) termed visceral ob...
BACKGROUND: Botulism is a rare but potentially fatal illness caused by botulinum neurotoxin, with outbreaks reported globally in humans, animals, and ...
Neck dissection is an essential part of surgical treatment for head and neck malignancies. In recent years, the extent of neck dissection required for...
OBJECTIVE: The Nottingham Histologic Grade (NHG) informs prognosis and treatment decisions in breast cancer, but NHG2 tumors are biologically heteroge...